Our story is a simple one of friendship, collaboration, and a vision for the future of clinical research.
With over 35 years of clinical trial experience, we understand the positive impact quality clinical research has on the lives of patients and their families.
PCRN is committed to helping pharmaceutical and biotech companies and CRO’s undertake patient driven trials to deliver solutions to the worlds disease burden.
Our centralised approach and integrated nationwide network of eleven private clinical research trial sites in New Zealand and access to four Australian based sites brings together the right expertise, technology, processes, and systems to overcome the challenges of implementing high-quality, timely and successful clinical studies.
This approach helps our clients:
- Access a diverse patient population across all New Zealand regions
- Achieve their recruitment targets
- Gain trial feasibility efficiencies
- Benefit from efficient and experienced ethics and regulatory approval process
- Increase efficiencies through one budget negotiation for all participating PCRN Sites
- Reduce study start up time
- Rapidly increase participant recruitment to advance study goals
- Gain excellent participant retention [PCRN’s average study retention is 99%]
- Achieve better quality data
- Monitoring Portal reduces time and cost of monitoring trial sites
Our capability
Our PCRN team has extensive experience across a broad range of primary healthcare and specialist therapeutic areas.
Recent completed trials include:
- Vaccine studies (Covid-19, RSV, influenza, hepatitis B, pneumococcal and HPV)
- Lipid lowering
- Diabetes
- Osteoarthritis
- Immune response
- Migraine
- Soft tissue injuries
- COPD
- Asthma
- Atopic dermatitis
- Rapid antigen devices
- Urticaria
- Aging
- Gout
- Endometriosis
- Cardiovascular outcomes
- Pain
- Depression
- Acute influenza
- Ophthalmology
Working with us
Working with your team, PCRN offers an integrated, experienced approach to conducting clinical research.
Our centralised approach improves efficiency, reduces cost and risk, and increases quality to maximise safety and efficiency and achieve greater levels of study success for sponsors and CRO’s. This includes:
- one centralised contract and budget negotiation
- fast delivery of high quality and meaningful data
- standardised SOPs across all trial sites
- a rapid and centralised ethics process
- leading edge technology such as CTMS with eSource, eDocs and data monitoring portal.
Rosie Mckellar
CEO
Dr Michael Williams
Medical Director
Julia Howell
Chief Commercial Officer
Philippa Williams
Chief Operating Officer
Jaimee Hart
Chief Financial Officer
Laura Carson
Executive Assistant
Paul Hamilton
Clinical Director - Early Phase
Kim Huljich
Ethics Administrator
Chloe Roberts
Data Entry Research Assistant
Jan Gaskin
Quality Manager
Ashleigh Williams
Accounts Administrator
Keziah Downes
Recruitment Specialist
Angela Chelet
Clinical Quality Associate
Network partner model
Our unique network partner model solution provides sponsors and CRO’s access to eleven primary and specialist healthcare clinics with a strong focus on combining research with patient care.
All our network partners have strong community outreach, a focus on safety and wellbeing and large, diverse participant databases to achieve fast and effective study recruitment.
PCRN works closely with all our network partners to help them navigate the complexities of patient recruitment and provide the right trial methodology, systems, and processes to achieve a more successful experience for both the sites and the patients.
Recent trial highlights
Covid Vaccine Trial:
- 163% over recruitment target.
- Total of 311 participants across PCRN network.
- PCRN site lead site for ethics.
- Approval in 19 days under expedited ethics pathway for Covid trials
Covid-19 Diagnostic Trial:
- 101% of recruitment target.
- Total of 177 participants over 9 days
- SIV to First Patient Visit 5 days
Obesity Study:
- PCRN Site 260% over recruitment target
Type 2 Diabetes and Albuminuria:
- PCRN Site 200% over recruitment target
Type 2 Diabetes and Obesity:
- PCRN Site 117% over recruitment target
Pneumococcal Vaccine Trial:
- 110% over recruitment target
Endometriosis Trial:
- 100% recruitment
Who we work with
Our sponsors and partners
Why Choose New Zealand
New Zealand is ranked sixth in the world in the 2022 Global Opportunity Index which reflects our stable economic environment and willingness of both governments to support high-quality local and international investment.
Take a look at the numbers
11th
Source:
0%
Source:
11th
Source:
3%
Source:
Source: NZTE
